Cell Mol Gastroenterol Hepatol . SARS-CoV-2 induces a more robust innate immune response and replicates less efficiently than SARS-CoV in the human intestines: an ex vivo study with implications on pathogenesis of COVID-19

[tetano]

Cell Mol Gastroenterol Hepatol


. 2020 Sep 30;S2352-345X(20)30160-0.
doi: 10.1016/j.jcmgh.2020.09.017. Online ahead of print.
SARS-CoV-2 induces a more robust innate immune response and replicates less efficiently than SARS-CoV in the human intestines: an ex vivo study with implications on pathogenesis of COVID-19


Hin Chu ¹ , Jasper Fuk-Woo Chan ² , Yixin Wang ³ , Terrence Tsz-Tai Yuen ³ , Yue Chai ³ , Huiping Shuai ³ , Dong Yang ³ , Bingjie Hu ³ , Xiner Huang ³ , Xi Zhang ³ , Yuxin Hou ³ , Jian-Piao Cai ³ , Anna Jinxia Zhang ¹ , Jie Zhou ¹ , Shuofeng Yuan ¹ , Kelvin Kai-Wang To ² , Ivan Fan-Ngai **** ⁴ , Tan To Cheung ⁵ , Ada Tsui-Lin Ng ⁵ , Ivy Hau-Yee Chan ⁵ , Ian Yu-Hong Wong ⁵ , Simon Ying-Kit Law ⁵ , Dominic Chi-Chung Foo ⁵ , Wai-Keung Leung ⁶ , Kwok-Yung Yuen ⁷



Affiliations

• PMID: 33010495
• DOI: 10.1016/j.jcmgh.2020.09.017

Abstract

Background and aims: Besides prominent respiratory involvement, gastrointestinal manifestations are commonly reported in Coronavirus Disease 2019 (COVID-19) patients. We compared infection of ex vivo human intestinal tissues by SARS-CoV-2 and SARS-CoV with respect to their replication kinetics and immune activation profile.
Methods: Human intestinal tissues were obtained from patients while undergoing surgical operations at the Queen Mary Hospital, Hong Kong. Upon surgical removal, the tissues were immediately processed and infected with SARS-CoV-2 or SARS-CoV. Replication kinetics were determined with immunohistochemistry, qRT-PCR, and plaque assays. Immune activation in the infected intestinal tissues was assessed by detecting the gene expression of interferons and representative pro-inflammatory cytokines and chemokines.
Results: SARS-CoV-2 could infect and productively replicate in the ex vivo human intestinal tissues with the release of infectious virus particles, but not in ex vivo human liver and kidney tissues. Importantly, SARS-CoV-2 replicated less efficiently than SARS-CoV, induced less cytopathology in the human intestinal epithelium, and induced a more robust innate immune response including the activation of both type I and type III interferons, than SARS-CoV in human intestinal tissues.
Conclusion: Using the ex vivo human intestinal tissues as a physiologically relevant model, our data indicated that SARS-CoV-2 could productively replicate in the human guts, suggesting the gastrointestinal tract might serve as an alternative route of virus dissemination. SARS-CoV-2 replicated less efficiently and induced less cytopathology than SARS-CoV in keeping with the clinical observations reported for SARS-2003 and COVID-19, which might be a result of the more robust immune activation by SARS-CoV-2 than SARS-CoV in the human intestine.

Keywords: COVID-19; SARS-CoV; SARS-CoV-2; immune activation; replication.